F, L., A, G., E, C., A, B., C, C., N, S., . . . F, P. (2001). Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: A multicenter, randomized, double-dummy study. Clinical Therapeutics, 23(5), 761-771.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
F, Luzza, et al. "Lansoprazole-based Triple Therapy Versus Ranitidine Bismuth Citrate-based Dual Therapy in the Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Multicenter, Randomized, Double-dummy Study."
Clinical Therapeutics 23, no. 5 (2001): 761-771.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
F, Luzza, et al. "Lansoprazole-based Triple Therapy Versus Ranitidine Bismuth Citrate-based Dual Therapy in the Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Multicenter, Randomized, Double-dummy Study."
Clinical Therapeutics, vol. 23, no. 5, 2001, pp. 761-771.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.